Latest Mifepristone Legal Debates Raise More Questions, Confusion for Health Care Professionals
Lanton Law speak with Pharmacy Times about the Supreme Court’s decision on Mifepristone. Click here for the interview.
Previous
Previous
Lanton Law Quoted in Pharmacy Times Article "FDA Approves First Nonprescription Daily Birth Control Pill"
Next
Next